DMD and Duchenne muscular dystrophy: For example, a Duchenne muscular dystrophy (DMD) patient treated with a high-dose AAV-packaged CRISPR transgene to restore dystrophin (the faulty DMD gene) expression led to an immune response and rapid death, possibly arising from a high level of accumulated vector genome (Lek et al., 2023).